期刊文献+

慢性乙型肝炎自然史的研究 被引量:47

Study on the natural history of chronic hepatitis B
原文传递
导出
摘要 目的 对乙型肝炎的自然史进行研究,为其预后判断、药物疗效的分析及药品经济学评估提供佐证。方法 采用回顾性方法随访6~18年前经肝穿病理组织学诊断的183例慢性乙型肝炎的远期转归、影响因素及其抗病毒治疗的远期作用。结果183例慢性乙型肝炎患者累计死亡20例(1.93%),发生肝硬化22例(11.02%),肝癌12例(6.56%)。累计5、10、15年生存率分别为97.27%、91.62%和84.47%。因乙型肝炎及其并发症死亡者占死亡原因的85.00%。累计肝癌5年、10年、15年发生率分别是0. 3.19%和11.56%。对照组247例死亡6例(2,43%),无1例发展为肝硬化和肝癌。慢性乙型肝炎患者的死亡率是普通人群的4.50倍。二者相比,肝硬化、肝癌和死亡的发生率差异均有显著性(P<0.005)。采用 Cox回归分析,高龄、病理损害重、HBeAg阳性是肝硬化的危险因素;高龄、病理损害重、男性是死亡的危险因素;未筛选出肝癌的危险因素。结论 慢性乙型肝炎的远期预后不良。 Objective By clarifying the natural history of chronic hepatitis B, to evaluate its long-term therapeutic outcome, antiviral drugs efficacy and economic significance. Methods A cohort of 183 (mean age of 31.75 ± 8.03 years, male/female ratio: 152:3 1) chronic hepatitis B patients with biopsy-proven and 247 cases of general population as control were followed up by retrospective cohort study. The follow-up time was 11.81±4.08 years. This study was focused on long-term clinical outcome including the rate of liver cirrhosis, hepatocellular carcinoma and death, the long-term effect of antiviral drugs and prognostic factors. Results In chronic hepatitis B patients, 22(12.02%) developed liver cirrhosis, 12(6.56%) hepatocellular carcinoma, and 20(10.93%) died. The cumulative survival probabilities were 9727%, 91.62%, and 84.47% in 5,10, and 15 years, respectively. The cumulative probabilities of HCC were 0.00%, 3.19%, and 11.56% in 5, 10, and 15 years, respectively. In 247 control subjects, 6 (2.43%) died, none of them developed cirrhosis or HCC. The rates of death, liver cirrhosis, and HCC in hepatitis B patients were markedly different (P<0.005) compared with controls. The overall mortality of hepatitis B patients was 4.50 folds of the general population. Cox multiple regression analysis showed that old age, severe histological injury, and the positive HBeAg were closely related to liver cirrhosis, while old age, severe histological injury, and male were major factors leading to death. The independent variable of predicted HCC was not found. Conclusions The long-term outcome of hepatitis B is poor.
出处 《中华肝脏病杂志》 CAS CSCD 2002年第1期46-48,共3页 Chinese Journal of Hepatology
基金 中青年肝病科研基金资助项目
关键词 慢性乙型肝炎 病毒性肝炎 自然史 研究 Chronic hepatitis B, chronic Viral hepatitis Natural history
  • 相关文献

参考文献4

  • 1Oi-Marco V, Lo-Iacono O, Camma C, et al. The long-term course of chronic hepatitis B. Hepatology, 1999, 30: 257-264.
  • 2Ikeda K, Satosh S, Suziki Y, et al. Disease progrossion and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol, 1998, 28: 930-938.
  • 3Fattovich G, Brollo L, Giustina G, et al. Natural history and prosgnostic factors for chronic hepatitis type B. Gut, 1991, 32: 294-298.
  • 4Lin SM, Sheen IS, Chien RN, et al. Long-term beneficical effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology, 1999, 29: 971-975.

同被引文献345

引证文献47

二级引证文献791

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部